Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | AR | P10275 | 5/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.38 |
| ▸ | MEN1 | O00255 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 2/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.37 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24564677 | 0.77 | MEN1 (0.47) | L3MBTL1MAPTALDH1A1TSHRAR | |
| SCHEMBL24564543 | 0.77 | MAPT (0.45) | L3MBTL1MAPTALDH1A1ARHSD17B10 | |
| SCHEMBL24564736 | 0.75 | LMNA (0.48) | L3MBTL1MAPTALDH1A1TSHRAR | |
| SCHEMBL24580988 | 0.75 | ALDH1A1 (0.48) | L3MBTL1MAPTALDH1A1TSHRHSD17B10 | |
| SCHEMBL24564746 | 0.75 | POLB (0.48) | L3MBTL1MAPTALDH1A1TSHRHSD17B10 | |
| SCHEMBL23957498 | 0.75 | MAPT (0.48) | L3MBTL1MAPTALDH1A1HRH3MEN1 | |
| SCHEMBL24564651 | 0.75 | ALDH1A1 (0.64) | MAPTALDH1A1TSHRHSD17B10KMT2A | |
| SCHEMBL24564664 | 0.74 | LMNA (0.50) | L3MBTL1MAPTALDH1A1TSHRHRH3 | |
| SCHEMBL24564614 | 0.74 | HTT (0.49) | L3MBTL1MAPTALDH1A1TSHRAR | |
| SCHEMBL24581224 | 0.72 | MAPT (0.45) | L3MBTL1MAPTALDH1A1HRH3LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022140464-A1 | COMPOUNDS AND METHODS FOR TREATING AUTOIMMUNE DISORDERS BY TARGETING HLA-DQ2 | IMMUNOMOLECULAR THERAPEUTICS, INC. (US) | 2022-06-30 | — | — | WO | disclosed |